When Brain Tumors and Pregnancy Collide: Navigating Cesarean Sections Safely
"A case study highlights the careful use of combined spinal-epidural anesthesia in a pregnant woman with a frontal glioma, challenging traditional contraindications and emphasizing personalized care."
The intersection of pregnancy and brain tumors presents a unique challenge in obstetric anesthesia. While intracranial neoplasms are relatively rare, affecting approximately 21.42 individuals per 100,000, their presence can significantly complicate the management of labor and delivery. Gliomas, the most common type of brain tumor, account for a substantial portion of these cases, raising concerns about potential neurological risks during childbirth.
Cesarean sections performed under neuraxial anesthesia (spinal or epidural) are a standard practice in North America, primarily due to the increased risk of difficult airways and aspiration associated with pregnancy. However, intracranial pathology has traditionally been considered a contraindication for neuraxial techniques. The concern stems from the potential for increased intracranial pressure (ICP), inadequate cerebrospinal fluid (CSF) flow, and the risk of herniation or neurological deterioration.
This article presents a compelling case of a pregnant patient with a known frontal glioma who underwent a cesarean section using a combined spinal-epidural anesthetic. This approach challenges the conventional wisdom surrounding neuraxial anesthesia in the presence of intracranial masses and highlights the importance of individualized assessment and collaborative decision-making.
Current Statistics & Impact
Brain tumors during pregnancy represent a rare but critical clinical scenario where maternal and fetal outcomes hinge on timely, coordinated care. The intersection of neurosurgical urgency and obstetric management creates complex decision-making around delivery timing and mode. While comprehensive population-level statistics remain limited, case literature highlights that intracranial tumors — particularly meningiomas and gliomas — can exhibit accelerated growth during pregnancy due to hormonal influences and hemodynamic changes.
Standard Approach, Accepted Methods & Their Limitations
Anesthetic management for cesarean delivery in patients with brain tumors traditionally favors general anesthesia with agents that minimize intracranial pressure elevation, such as thiopental or propofol, combined with controlled ventilation. Regional techniques have been historically avoided due to theoretical risks of herniation from CSF pressure changes, though recent reports describe successful combined spinal-epidural approaches with meticulous hemodynamic control. Key limitations include balancing maternal neuroprotection against fetal exposure to anesthetic agents, and the challenge of coordinating neurosurgical and obstetric teams for either staged or single-session procedures. Postoperative elective ventilation is often planned for 24–36 hours when tumor resection follows cesarean section.
Historical Perspective, Milestones, Foundational Discoveries
The management of brain tumors in pregnancy has evolved from near-universal pregnancy termination or maternal sacrifice to multidisciplinary strategies preserving both lives. Early case reports from the 1970s–1990s documented the use of high-dose barbiturates and controlled hypotension to attenuate intracranial pressure surges during cesarean delivery. The concept of single-session cesarean section and craniotomy emerged as a milestone in the 2000s, reducing anesthetic exposures and logistical complexity. Foundational work established that pregnancy-associated hormonal fluctuations — particularly progesterone and estrogen — can drive meningioma growth via receptor-mediated pathways.
The Case: Balancing Risks and Benefits
A 32-year-old woman (G3P2) at 35 weeks' gestation was admitted to the hospital due to decreased fetal movement, a non-reassuring fetal heart rate, and an asthma exacerbation. Her medical history was significant for several factors:
- Asthma requiring home nebulizers.
- Obesity with a body mass index of 53.
- Known frontal glioma.
- Seizure disorder.
- Migraines.
Latest Research and Reviews
A 2025 systematic review examined the feasibility of same-session meningioma resection and cesarean section, synthesizing existing case literature and presenting a technical example with surgical indications and outcomes. Recent case reports describe successful combined spinal-epidural anesthesia for cesarean delivery in parturients with brain tumors, emphasizing careful planning and interdisciplinary collaboration. A 2023 report documented clinical improvement and tumor regression postpartum in a patient with intracranial bleeding who underwent cesarean section under general anesthesia, suggesting a possible role of pregnancy hormone withdrawal in tumor dynamics. Advances in diagnostic imaging and molecular characterization continue to refine preoperative planning and prognostication for these rare cases.
Counter Arguments and Failures
Post-cesarean maternal morbidity remains significant even without neurosurgical comorbidity, with common complications including hemorrhage, infection, fatigue, sleep disorders, breast problems, and self-care difficulties. In the brain tumor context, historical reliance on high-dose thiobarbiturates and general anesthesia carries risks of neonatal depression and maternal hemodynamic instability, particularly in posterior fossa lesions where brainstem compression can worsen with induction. The theoretical contraindication to neuraxial anesthesia in elevated intracranial pressure persists in some guidelines despite emerging evidence of safety with controlled techniques. Failed intubations, difficult airways, and intraoperative tumor hemorrhage represent catastrophic failure modes that demand preoperative contingency planning.
Comparative Analysis
The 2011 British Journal of Anaesthesia report endorsed single-anesthetic cesarean section and tumor resection as a coordinated strategy, noting normal preoperative assessment in their case. More recent neuraxial anesthesia guidelines for cesarean delivery (2025) emphasize that anesthetic choice must account for patient-specific, obstetric, surgical, and anesthesia-related factors — not all cesareans or neuraxial blocks are equivalent. Comparative data remain limited to case series; no randomized trials exist. Key comparative variables include tumor location (supratentorial vs. posterior fossa), size, vascularity, and whether resection is emergent or elective. General anesthesia offers airway control and predictable hemodynamics but risks intracranial pressure spikes at intubation; neuraxial techniques avoid airway manipulation but require careful titration to prevent sympathectomy-induced hypotension.
Challenging Dogma, Embracing Collaboration
This case challenges the traditional contraindication of neuraxial techniques in patients with intracranial masses. It underscores the importance of careful patient selection, thorough evaluation, and collaborative decision-making between anesthesia, neurosurgery, and obstetrics. By carefully weighing the risks and benefits of different anesthetic approaches, and by prioritizing patient safety and individualized care, successful outcomes can be achieved even in complex obstetric scenarios.
Synthesis & Expert Commentary
Multidisciplinary tumor boards at specialized centers report successful outcomes with simultaneous cesarean section and tumor resection at gestations as early as 26 weeks, with both mother and neonate in good condition. Pituitary tumors presenting with visual field defects in late pregnancy (e.g., 37 weeks) represent a distinct phenotype where urgent decompression after delivery can reverse deficits. Expert consensus emphasizes individualized timing — balancing fetal maturity against maternal neurological deterioration — and anesthetic plans tailored to tumor physiology rather than rigid protocols.
Future Outlook & Next Frontiers
Future directions include prospective registries to define optimal delivery timing and anesthetic technique by tumor histology and location, as well as investigation of molecular drivers linking pregnancy hormones to tumor proliferation. Neuraxial ultrasound guidance and real-time intracranial pressure monitoring may expand safe regional anesthesia candidacy. Emerging targeted therapies for meningiomas (e.g., FAK inhibitors, somatostatin analogs) could alter the natural history in pregnant patients, potentially deferring resection. Fetal neuroprotection strategies during maternal neurosurgery remain an unexplored frontier.
Broader Context & Systemic Challenges
Anesthetic management of parturients with known intracranial meningiomas requires preoperative optimization including anticonvulsants and steroids, with careful attention to tumor size (e.g., 5.2 cm sphenoid meningioma at 37 weeks) and edema. Systemic challenges include limited access to tertiary centers capable of combined obstetric-neurosurgical care, especially in resource-constrained settings. A provocative 2018 murine study found cesarean delivery itself alters offspring brain development profoundly and widespread, raising questions about long-term neurodevelopmental impacts when cesarean is performed under the additional stress of maternal brain tumor pathophysiology.
The Human Element & Real-World Impact
Case reports illustrate the profound personal impact: a full-term pregnancy complicated by a giant intracranial meningioma requiring emergency cesarean and craniotomy in a single session, and a 29-year-old primigravida at 31 weeks with an inoperable brainstem astrocytoma diagnosed eight years prior, facing scheduled cesarean with uncertain maternal prognosis. Literature reviews accompanying these cases highlight how pregnancy can accelerate tumor growth, the diagnostic dilemmas of attributing neurological symptoms to pregnancy versus tumor progression, and the agonizing management decisions families confront when maternal survival and fetal viability hang in balance.